Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of CKD Progression in Type 1 Diabetes With Long Term Use of SGLTi Avoiding Kidney hypOxia(PLUTO)

NCT06147232 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.

NCT NCT06147232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06147232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of CKD Progression in Type 1 Diabetes With Long Term Use of SGLTi Avoiding Kidney hypOxia(PLUTO)
Lead sponsor
Steno Diabetes Center Copenhagen
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
May 31, 2027
Enrollment
69 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, diabetes mellitus, type 1, diabetic complications cardiovascular, diabetic complications renal, diabetic nephropathies, hypoxia, nephropathy